The average THC content of cannabis roughly tripled between the mid-1990s and the mid-2010s, rising from about 4 percent to roughly 12 percent, according to a Yahoo Health report. It has continued to climb since then.
Concentrates, vape oils, and dabs now reach 60 to 90 percent THC, an exposure with no historical precedent. Much of the reassuring older research was conducted on a far weaker product.
The report notes that dose drives risk. When the dose of a psychoactive drug increases by that magnitude, its risk profile cannot be assumed to stay the same.
The public’s intuition that cannabis is mild is based on a product that has largely been replaced. The harms now documented track closely with potency and frequency of use.
Since 2012, when the first states legalized recreational cannabis, most states now permit medical use and roughly half permit recreational use. By 2022, the number of Americans using cannabis daily or near-daily exceeded the number drinking alcohol.
Roughly three in ten people who use cannabis show some degree of cannabis use disorder, an inability to control use despite harm. The risk is higher among daily users and those who begin in adolescence.
Withdrawal symptoms, including irritability, sleep disturbance, and cravings, are recognized symptoms. The report states that the claim cannabis is not addictive is false.
Daily use of high-potency cannabis was associated with a fivefold increase in the odds of a psychotic disorder compared with never using. The association is strong and dose-dependent, though causation remains debated.
Some long-term heavy users develop hyperemesis syndrome, recurrent episodes of severe, intractable vomiting, often relieved only by hot showers or baths. It is frequently misdiagnosed and drives repeated emergency visits.
Large analyses have also linked cannabis use to higher rates of heart attack and stroke, in a dose-dependent pattern. The association persists even among people who have never smoked tobacco.
As use rose and legalization spread, the public’s perception of cannabis as risky fell, particularly among adolescents. The report calls this mismatch a central public-health finding of the legalization era.
Legality reinforced the impression of safety because people tend to infer that what the state permits and taxes must be safe. The report notes that legal status is a policy decision, and alcohol and tobacco remain legal but harmful.
A separate analysis in JAMA found a modest benefit for chronic pain and spasticity. Purified CBD is an approved prescription drug for two rare and severe childhood epilepsies.
The report concludes that cannabis is a psychoactive drug with a modest therapeutic niche and a harm profile that scales with dose, potency, frequency, and youth.
Boots Becomes First UK Pharmacy Chain To Prescribe Medical Cannabis Boots is to start prescribing medicinal cannabis in a first…
Bail Restrictions Expand In Three States Millions of voters in 11 states weighed in on criminal justice and drug policies…
Boots Becomes First UK High Street Pharmacy To Prescribe Medical Cannabis Boots is to start prescribing medical cannabis, it has…
Senate Leader Signals Legalization Is Not a Top Priority Presumptive Senate President Pro Tempore Jay Costa (D) told WHTM-TV in…
The Bill and Its Sponsor Rep. Steve Cohen (D-Tenn.) has introduced the Public Health and Research Reforms in Controlled Substances…
Hemp Retailers Liquidate Inventory Ahead of Ban Hemp retailers across Missouri slashed prices, cleared shelves and, in some cases, gave…